Cerence

CRNC slipped to $8.51 pre-market and opened the regular session at $8.456, its low of the day, then ground steadily higher to a $9.230 peak at 15:15 ET and closed at $9.175, up 5.3% from the prior close of $8.715, with post-market holding near $9.17. The move tracked the disclosure of a robotics technology services partnership with Geely, layered on a fiscal Q3 that showed revenue of $69.59M, up 11.8% y/y, net income of $1.53M, up 156%, and operating income of $3.13M, while the consensus price target was raised 34.28% from MX$175.9 to MX$236.13. Even after the rally the stock is down 20.67% year to date, sits roughly 32% below its 52-week high of $13.49 and about 57% above its 52-week low of $5.85, though it has reclaimed the MA20 at $8.21 and MA60 at $8.359. Q3 revenue still landed slightly below estimates as the professional services segment dragged, an EVP sold more than $529K of stock, the regular session traded only about 575,000 shares, and the trailing PE remains negative at -26.94.

CRNC reversed an early dip into a rally and gave back part of it into the close on Monday, bouncing from an 8.52 low to 9.22 by 11:21 ET before settling up 1.6% at 8.885, with post-market flat at 8.890, driven by FY26 Q3 revenue up 11.81% yoy to $69.59M, GAAP net income swinging to $1.53M and EPS of $0.03, up 147.7%, though the 8-K flagged that revenue still came in slightly below estimates and last quarter's -17.71% revenue print leaves the improvement base fragile. The stock has reclaimed its MA20 at 8.116 and MA60 at 8.374 but sits 34.1% below its 52-week high of $13.49 and down 23.1% year to date, while still 51.97% above the March 30 low of $5.85; market cap is $402M with PB at 2.42. Insider moves cut both ways, with the EVP selling over $529K while the CFO bought $14,040. However, post-market volume of just 9,534 shares and a 2.39% turnover rate leave the rebound unconfirmed.

CRNC staged a low-open, dip-buying rebound, closing at $8.75 against a prior close of $8.43, a gain of roughly 3.8%: pre-market drifted between $8.45 and $8.64, the regular session opened at $8.32 at 09:30 ET — the day's low — then ground higher to an intraday peak of $8.935 at 14:13 ET before settling at $8.76, with after-hours flat at $8.75. The move aligns with improving Q3 2026 fundamentals, when revenue rose 11.81% year over year to $69.587M while operating income of $3.134M and net income of $1.533M both swung to positive, even though revenue still fell slightly short of estimates as professional services weighed. The shares now sit above the MA20 of $8.073 and MA60 of $8.369, yet remain down 24.31% year to date, 35.14% below the 52-week high of $13.49 and 49.57% above the 52-week low of $5.85 set on 30 March. Internal signals are mixed, though, with the EVP selling over $529K while the CFO bought $14,040.

Cerence staged an intraday rebound on Oct 7, closing at 8.29 USD, up 2.72% from 8.07 USD, after opening at 7.95 USD and dipping to 7.825 USD at 10:53 ET before rallying to 8.34 USD by 15:56 ET; the move followed the repurchase of part of its 2028 convertible notes and a partnership with Advanced Smart Mobility to deploy emergency vehicle detection on autonomous buses in Japan. For FY26 Q3 revenue was 69.59M USD, up 11.81% yoy, with net income of 1.53M USD, up 156%, though revenue landed slightly below estimates as professional services weighed. The stock still trades below its MA60 of 8.412 USD and above MA20 of 8.047 USD, down 28.29% YTD and 38.55% under its 52-week high of 13.49 USD, with a 374.96M USD market cap, PB of 2.25 and negative PE. Though the consensus price target was raised 34.28% to MX$236.13.

Cerence (CRNC) surged to an intraday high of $8.120 during regular trading and closed at $8.149, up 5.42%, driven by pre-market news of its partial repurchase of 2028 convertible notes and a partnership with Advanced Smart Mobility for emergency vehicle detection on autonomous buses in Japan. Financially, Q3 revenue rose 11.81% year-over-year to $69.59 million, with net profit swinging to $1.53 million, yet prior Q3 results slightly missed estimates, weighing on the stock. Currently, the price is 40.68% below its 52-week high of $13.738, down 29.51% year-to-date, and trades below both the 20-day MA ($8.217) and 60-day MA ($8.943), suggesting limited valuation recovery, though ongoing interest in AI patents and mobility deals may offer support.